Matches in Wikidata for { <http://www.wikidata.org/entity/Q61921663> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q61921663 description "assaig clínic" @default.
- Q61921663 description "clinical trial" @default.
- Q61921663 description "clinical trial" @default.
- Q61921663 description "clinical trial" @default.
- Q61921663 description "clinical trial" @default.
- Q61921663 description "ensaio clínico" @default.
- Q61921663 description "ensayo clínico" @default.
- Q61921663 description "ensayu clínicu" @default.
- Q61921663 description "essai clinique" @default.
- Q61921663 description "klinisch onderzoek" @default.
- Q61921663 description "клінічне випробування" @default.
- Q61921663 description "կլինիկական փորձարկում" @default.
- Q61921663 description "临床试验" @default.
- Q61921663 name "Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension." @default.
- Q61921663 type Item @default.
- Q61921663 label "Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension." @default.
- Q61921663 prefLabel "Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension." @default.
- Q61921663 P1050 Q61921663-25904B85-09C6-4614-BC8D-AE6F91B585D5 @default.
- Q61921663 P1132 Q61921663-3507CFDC-F68C-4C70-B4B7-9BAE79AA4BCB @default.
- Q61921663 P1476 Q61921663-C2AF186B-528A-4D19-9C1C-1A1FB9137313 @default.
- Q61921663 P2899 Q61921663-F22E82D7-4503-4101-A7C5-5BA045E9070B @default.
- Q61921663 P3098 Q61921663-10D5D1C1-4758-488C-80EF-023F1A3DBDEE @default.
- Q61921663 P31 Q61921663-558FA067-60C8-4B33-84E4-41E2D3385C95 @default.
- Q61921663 P4844 Q61921663-32971E76-5018-4FC4-AA31-7DE2CBA05FEE @default.
- Q61921663 P580 Q61921663-249CD5B9-6FB9-40B9-9331-B29BCA032F81 @default.
- Q61921663 P6099 Q61921663-C3867A50-2BDA-49AD-8CA4-316CCA5EEA4F @default.
- Q61921663 P8005 Q61921663-647F779E-63BB-4031-8838-C32C942C6DB9 @default.
- Q61921663 P8363 Q61921663-22726C52-B987-431A-A99A-94E1ADC94A5A @default.
- Q61921663 P859 Q61921663-7FE9CAD1-278E-4BAE-816F-B70DC5AE9320 @default.
- Q61921663 P1050 Q41861 @default.
- Q61921663 P1132 "+186" @default.
- Q61921663 P1476 "Ambrisentan in PAH - A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Study of Ambrisentan in Subjects With Pulmonary Arterial Hypertension" @default.
- Q61921663 P2899 "+18" @default.
- Q61921663 P3098 "NCT00423748" @default.
- Q61921663 P31 Q30612 @default.
- Q61921663 P4844 Q410789 @default.
- Q61921663 P580 "2003-12-01T00:00:00Z" @default.
- Q61921663 P6099 Q42824827 @default.
- Q61921663 P8005 Q76651189 @default.
- Q61921663 P8363 Q78089383 @default.
- Q61921663 P859 Q663596 @default.